Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - pharmaceutical product: Difference between revisions

From GxPlex

Jump to: navigation, search
imported>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|has_document=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|RefScope=HM
|module=1
|RefDocPart=Glossary - pharmaceutical product
|unit=1.2.2
|RefLanguage=EN
|scope=HM
|RefTags=TAG-00001-Med-rzn ++ TAG-00244-Def-ini
|doc_part=Glossary - pharmaceutical product
|RefModule=1
|language=EN
|RefUnit=1.2.2
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00001-Med-rzn ++ TAG-00244-Def-ini
|tags_display=[[Glossary:TAG-00001-Med-rzn|Medicinal product]], [[Glossary:TAG-00244-Def-ini|Definition]]
|comment=Definition of pharmaceutical product
|content=pharmaceutical product
Any substance or combination of substances which has a therapeutic, prophylactic or diagnostic use, or is intended to modify physiological functions, and is presented in a dosage form suitable for administration to humans.
}}
}}
{{:Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995}}
{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 1 — Unit 1.2.2
|-
! Scope
| HM
|-
! Document part
| Glossary - pharmaceutical product
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00001-Med-rzn|Medicinal product]], [[Glossary:TAG-00244-Def-ini|Definition]]
|-
! Comment
| Definition of pharmaceutical product
|}
== Content ==
pharmaceutical product
Any substance or combination of substances which has a therapeutic, prophylactic or diagnostic use, or is intended to modify physiological functions, and is presented in a dosage form suitable for administration to humans.

Latest revision as of 13:49, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.2.2
Scope HM
Document part Glossary - pharmaceutical product
Language EN
Original entry by Florian Adragna
Contributors
Tags Medicinal product, Definition

Content

pharmaceutical product Any substance or combination of substances which has a therapeutic, prophylactic or diagnostic use, or is intended to modify physiological functions, and is presented in a dosage form suitable for administration to humans.